Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Non Operating Income (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Non Operating Income for 13 consecutive years, with -$3.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income fell 704.01% year-over-year to -$3.6 million, compared with a TTM value of -$13.0 million through Dec 2025, down 279.34%, and an annual FY2025 reading of -$13.0 million, down 279.34% over the prior year.
  • Non Operating Income was -$3.6 million for Q4 2025 at Tandem Diabetes Care, down from -$2.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $4.2 million in Q1 2023 and bottomed at -$5.9 million in Q2 2025.
  • Average Non Operating Income over 5 years is $23100.0, with a median of -$283500.0 recorded in 2022.
  • The sharpest move saw Non Operating Income skyrocketed 687.76% in 2023, then tumbled 704.01% in 2025.
  • Year by year, Non Operating Income stood at -$1.6 million in 2021, then skyrocketed by 204.46% to $1.7 million in 2022, then skyrocketed by 125.36% to $3.8 million in 2023, then tumbled by 84.05% to $598000.0 in 2024, then plummeted by 704.01% to -$3.6 million in 2025.
  • Business Quant data shows Non Operating Income for TNDM at -$3.6 million in Q4 2025, -$2.3 million in Q3 2025, and -$5.9 million in Q2 2025.